Accessibility Menu
Bonesupport Ab (publ) logo

Bonesupport Ab (publ)(OTC) BOEUF

Market Cap$1.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+277%
5 Year+197%
1 Year-37%
1 Month-10%
$20.49
+0.00%
+0.00Today
Bonesupport Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 20.492026-07-20
Bonesupport Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.28%USD 21.402026-06-23
1 month-10.11%USD 22.792026-06-16
3 month-28.12%USD 28.502026-04-20
Year to date+3.49%USD 19.802025-12-31
1 year-36.97%USD 32.502025-07-16
3 year+248.38%USD 5.882023-04-28
5 year+196.88%USD 6.902021-04-12
Since inception+276.56%USD 5.442020-07-08

Bonesupport Ab (publ) Financials at a Glance

Market Cap

$1.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.28B

Net Income (TTM)

SEK 213.57M

EPS (TTM)

$0.34

P/E Ratio

58.92

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Price

$20.49

Volume

400

Open

$20.49

Previous Close

$20.49

Daily Range

$20.49 - $20.49

52-Week Range

$18.57 - $34.10

Estimated Earnings Date

Oct 22, 2026

BOEUF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bonesupport Ab (publ)

Bonesupport Holding AB (publ) is an innovative orthobiologics company specializing in injectable bioceramic solutions for treating bone voids. The company operates globally, with a strong presence in Europe and North America, focusing on enhancing patient outcomes through advanced medical technologies.

Products and Services
  • CERAMENT Bone Void Filler, a synthetic injectable material
  • CERAMENT G, a ceramic bone graft substitute infused with gentamicin
  • CERAMENT V, a synthetic bone void filler containing vancomycin
Growth Outlook
  • Revenue increased to SEK 355.7 million in Q2 2026, up from SEK 324 million in Q1 2026
  • Operating income margin improved to 25.2% in Q2 2026
  • Strong cash flow generation supports ongoing product development and market expansion
Financial Highlights
  • Net income of SEK 81.9 million reported in Q2 2026
  • Gross profit margin maintained at approximately 90% over recent quarters
  • Current ratio of 5.44 indicates strong liquidity position
Bonesupport Holding AB (publ) has established itself as a leader in the orthobiologics sector, with a focus on innovative solutions that address critical medical needs. The company's flagship products, including CERAMENT Bone Void Filler, are designed to enhance bone healing and regeneration, making them essential in various surgical applications. The recent financial performance reflects a robust growth trajectory, with significant revenue increases and strong profit margins. The company's liquidity position is solid, allowing for continued investment in research and development, which is crucial for maintaining competitive advantage in the evolving healthcare landscape. As the demand for advanced medical devices continues to rise, Bonesupport is well-positioned to capitalize on emerging opportunities in the orthobiologics market.
AI Generated • Jul 23, 2026

Industry

Biotechnology

Sector

Health Care

Employees

139

CEO

Torbjörn Sköld, MBA

Website

www.bonesupport.com

Headquarters

Lund, SN 223 70, SE

BOEUF Financials

Key Financial Metrics (TTM)

Gross Margin

92.05%

Operating Margin

24.28%

Net Income Margin

16.63%

Return on Equity

23.82%

Return on Capital

31.66%

Return on Assets

19.10%

Earnings Yield

1.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

65.49M

Volume

400

Avg. Volume

68.127

Financials (TTM)

Gross Profit

SEK 1.18B

Operating Income

SEK 311.60M

EBITDA

SEK 313.87M

Operating Cash Flow

SEK 276.53M

Capital Expenditure

-SEK 4.30M

Free Cash Flow

SEK 272.23M

Cash & ST Invst.

SEK 434.31M

Total Debt

SEK 17.73M

Bonesupport Ab (publ) Performance Analysis

Bonesupport Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 32,492,23931.0%
20232023-12-31SEK 55,678,23371.4%
20242024-12-31SEK 85,004,24452.7%
20252025-12-31SEK 119,771,59640.9%
Bonesupport Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.7%
Q42025-12-316.7%
Q12026-03-313.9%
Q22026-06-309.8%
Bonesupport Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -0.10-32.9%
20232023-12-31SEK 0.35N/A
20242024-12-31SEK 0.19-46.0%
20252025-12-31SEK 0.2214.3%
Bonesupport Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-35.4%
Q42025-12-3129.4%
Q12026-03-3121.2%
Q22026-06-3053.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 355.72M

+25.1%

Gross Profit

SEK 323.02M

+23.0%

Gross Margin

90.81%

N/A

Market Cap

$1.34BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$8.38M

N/A

Employees

160

N/A

Net Income

SEK 81.88M

+54.3%

EBITDA

SEK 91.70M

+61.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 434.31M

+40.2%

Total Debt

SEK 17.73M

+32.2%

Accounts Receivable

SEK 221.71M

+16.4%

Inventory

SEK 167.56M

+26.6%

Long Term Debt

SEK 2.45M

-56.8%

Short Term Debt

SEK 15.26M

+97.0%

Return on Assets

19.10%

N/A

Return on Invested Capital

32.76%

N/A

Free Cash Flow

SEK 64.60M

+35.0%

Operating Cash Flow

SEK 67.09M

+34.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRRMFGerresheimer AG
$31.68+2.83%
GTBIFGreen Thumb Industries Inc.
$7.10+1.28%
EKTAFElekta AB (publ)
$5.18-1.33%
EKTAYElekta AB (publ)
$5.05-0.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About BOEUF

What is the current price of Bonesupport Ab (publ)?

Bonesupport Ab (publ) is trading at $20.49 per share.

What is the 52-week range for Bonesupport Ab (publ)?

Over the past 52 weeks, Bonesupport Ab (publ) has traded between $18.57 and $34.10.

How much debt does Bonesupport Ab (publ) have?

As of the most recent reporting period, Bonesupport Ab (publ) reported total debt of SEK 1.05M.

How much cash does Bonesupport Ab (publ) have on hand?

Bonesupport Ab (publ) reported SEK 44.88M in cash and cash equivalents in its most recent financial results.

What is Bonesupport Ab (publ)’s dividend yield?

Bonesupport Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services